Anne Layne-Farrar is speaking at this conference on “Evolving Antitrust IP Guidelines across Asia – What’s ahead for technology and pharma?”.
For more information on this conference, click here.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...